83 results on '"Larizza, D."'
Search Results
2. Collectrin gene screening in Turner syndrome patients with kidney malformation
- Author
-
Pasquali, L., d’Annunzio, G., Gastaldi, R., Di Battista, E., Calcaterra, V., Larizza, D., Lorini, R., and D’Amato, E.
- Published
- 2009
- Full Text
- View/download PDF
3. Correction to: Variation in neurosurgical management of traumatic brain injury: a survey in 68 centers participating in the CENTER-TBI study (Acta Neurochirurgica, (2019), 161, 3, (435-449), 10.1007/s00701-018-3761-z)
- Author
-
van Essen T. A., van Essen, T, den Boogert, H, Cnossen, M, de Ruiter, G, Haitsma, I, Polinder, S, Steyerberg, E, Menon, D, Maas, A, Lingsma, H, Peul, W, Ackerlund, C, Adams, H, Agnoletti, V, Allanson, J, Amrein, K, Andaluz, N, Andelic, N, Andreassen, L, Antun, A, Anke, A, Antoni, A, Ardon, H, Audibert, G, Auslands, K, Azouvi, P, Azzolini, M, Baciu, C, Badenes, R, Bartels, R, Larizza, D, Barzo, P, Bauerfeind, U, Beauvais, R, Beer, R, Belda, F, Bellander, B, Belli, A, Bellier, R, Benali, H, Benard, T, Berardino, M, Beretta, L, Beynon, C, Bilotta, F, Binder, H, Biqiri, E, Blaabjerg, M, Bouzat, P, Bragge, P, Brazinova, A, Brinck, V, Brooker, J, Brorsson, C, Buki, A, Bullinger, M, Calappi, E, Calvi, M, Cameron, P, Carbayo, L, Carbonara, M, Carise, E, Carpenter, K, Castano-Leon, A, Causin, F, Chevallard, G, Chieregato, A, Citerio, G, Coburn, M, Coles, J, Coles-Kemp, L, Collett, J, Cooper, J, Correia, M, Covic, A, Curry, N, Czeiter, E, Czosnyka, M, Dahyot-Fizelier, C, Damas, F, Damas, P, Dawes, H, De Keyser, V, Della, C, Depreitere, B, Dilvesi, D, Ding, S, Dippel, D, Dixit, A, Donoghue, E, Dreier, J, Duliere, G, Eapen, G, Engemann, H, Ercole, A, Esser, P, Ezer, E, Fabricius, M, Feigin, V, Feng, J, Foks, K, Fossi, F, Francony, G, Freo, U, Frisvold, S, Furmanov, A, Gagliardo, P, Galanaud, D, Gantner, D, Gao, G, Geleijns, K, George, P, Ghuysen, A, Giga, L, Giraud, B, Glocker, B, Golubovic, J, Gomez, P, Grossi, F, Gruen, R, Gupta, D, Haagsma, J, Hartings, J, Helbok, R, Helseth, E, Hertle, D, Hoedemaekers, A, Hoefer, S, Horton, L, Huijben, J, Hutchinson, P, Haberg, A, Jacobs, B, Jankowski, S, Jarrett, M, Jelaca, B, Jiang, J, Jones, K, Kamnitsas, K, Karan, M, Katila, A, Kaukonen, M, Kerforne, T, Kivisaari, R, Kolias, A, Kolumban, B, Kompanje, E, Kolundzija, K, Kondziella, D, Koskinen, L, Kovacs, N, Lagares, A, Lanyon, L, Laureys, S, Lecky, F, Ledig, C, Lefering, R, Legrand, V, Lei, J, Levi, L, Lightfoot, R, Loeckx, D, Lozano, A, Macdonald, S, Maegele, M, Majdan, M, Major, S, Manara, A, Manley, G, Martin, D, Martin, L, Martino, C, Maruenda, A, Marechal, H, Masala, A, Mattern, J, Mcfadyen, C, Mcmahon, C, Melegh, B, Menovsky, T, Morganti-Kossmann, C, Mulazzi, D, Muraleedharan, V, Murray, L, Muhlan, H, Nair, N, Negru, A, Nelson, D, Newcombe, V, Nieboer, D, Noirhomme, Q, Nyiradi, J, Oddo, M, Oldenbeuving, A, Oresic, M, Ortolano, F, Palotie, A, Parizel, P, Patruno, A, Payen, J, Perera, N, Perlbarg, V, Persona, P, Piippo-Karjalainen, A, Pili, F, Pirinen, M, Ples, H, Poca, M, Pomposo, I, Posti, J, Puybasset, L, Radoi, A, Ragauskas, A, Raj, R, Rambadagalla, M, Real, R, Rehorcikova, V, Rhodes, J, Ripatti, S, Rocka, S, Roe, C, Roise, O, Roks, G, Rosand, J, Rosenfeld, J, Rosenlund, C, Rosenthal, G, Rossaint, R, Rossi, S, Rueckert, D, Rusnak, M, Sacchi, M, Sahakian, B, Sahuquillo, J, Sakowitz, O, Sala, F, Sanchez-Porras, R, Sandor, J, Santos, E, Sasu, L, Savo, D, Schaffer, N, Schipper, I, Schlosser, B, Schmidt, S, Schoechl, H, Schoonman, G, Schou, R, Schwendenwein, E, Scholl, M, Sir, O, Skandsen, T, Smakman, L, Smeets, D, Smielewski, P, Sorinola, A, Stamatakis, E, Stanworth, S, Steinbuchel, N, Stevanovic, A, Stevens, R, Stewart, W, Stocchetti, N, Sundstrom, N, Synnot, A, Taccone, F, Takala, R, Tamas, V, Tanskanen, P, Taylor, M, Te Ao, B, Tenovuo, O, Telgmann, R, Teodorani, G, Theadom, A, Thomas, M, Tibboel, D, Tolias, C, Tshibanda, J, Trapani, T, Tudora, C, Vajkoczy, P, Vallance, S, Valeinis, E, Van der Steen, G, van der Jagt, M, van der Naalt, J, van Dijck, J, Van Hecke, W, van Heugten, C, Van Praag, D, Vande Vyvere, T, Van Waesberghe, J, Vanhaudenhuyse, A, Vargiolu, A, Vega, E, Velt, K, Verheyden, J, Vespa, P, Vik, A, Vilcinis, R, Vizzino, G, Vleggeert-Lankamp, C, Volovici, V, Voormolen, D, Vulekovic, P, Vamos, Z, Wade, D, Wang, K, Wang, L, Wessels, L, Wildschut, E, Williams, G, Wilson, L, Winkler, M, Wolf, S, Ylen, P, Younsi, A, Zaaroor, M, Zhihui, Y, Ziverte, A, Zumbo, F, van Essen T. A., den Boogert H. F., Cnossen M. C., de Ruiter G. C. W., Haitsma I., Polinder S., Steyerberg E. W., Menon D., Maas A. I. R., Lingsma H. F., Peul W. C., Ackerlund C., Adams H., Agnoletti V., Allanson J., Amrein K., Andaluz N., Andelic N., Andreassen L., Antun A., Anke A., Antoni A., Ardon H., Audibert G., Auslands K., Azouvi P., Azzolini M. L., Baciu C., Badenes R., Bartels R., Larizza D., Barzo P., Bauerfeind U., Beauvais R., Beer R., Belda F. J., Bellander B. -M., Belli A., Bellier R., Benali H., Benard T., Berardino M., Beretta L., Beynon C., Bilotta F., Binder H., Biqiri E., Blaabjerg M., den Boogert H., Bouzat P., Bragge P., Brazinova A., Brinck V., Brooker J., Brorsson C., Buki A., Bullinger M., Calappi E., Calvi M. R., Cameron P., Carbayo L. G., Carbonara M., Carise E., Carpenter K., Castano-Leon A. M., Causin F., Chevallard G., Chieregato A., Citerio G., Cnossen M., Coburn M., Coles J., Coles-Kemp L., Collett J., Cooper J. D., Correia M., Covic A., Curry N., Czeiter E., Czosnyka M., Dahyot-Fizelier C., Damas F., Damas P., Dawes H., De Keyser V., Della C. F., Depreitere B., Dilvesi D., Ding S., Dippel D., Dixit A., Donoghue E., Dreier J., Duliere G. -L., Eapen G., Engemann H., Ercole A., Esser P., Ezer E., Fabricius M., Feigin V. L., Feng J., Foks K., Fossi F., Francony G., Freo U., Frisvold S., Furmanov A., Gagliardo P., Galanaud D., Gantner D., Gao G., Geleijns K., George P., Ghuysen A., Giga L., Giraud B., Glocker B., Golubovic J., Gomez P. A., Grossi F., Gruen R. L., Gupta D., Haagsma J. A., Hartings J. A., Helbok R., Helseth E., Hertle D., Hoedemaekers A., Hoefer S., Horton L., Huijben J., Hutchinson P. J., Haberg A. K., Jacobs B., Jankowski S., Jarrett M., Jelaca B., Jiang J. -Y., Jones K., Kamnitsas K., Karan M., Katila A., Kaukonen M., Kerforne T., Kivisaari R., Kolias A. G., Kolumban B., Kompanje E., Kolundzija K., Kondziella D., Koskinen L. -O., Kovacs N., Lagares A., Lanyon L., Laureys S., Lecky F., Ledig C., Lefering R., Legrand V., Lei J., Levi L., Lightfoot R., Lingsma H., Loeckx D., Lozano A., MacDonald S., Maegele M., Majdan M., Major S., Manara A., Manley G., Martin D., Martin L. F., Martino C., Maruenda A., Marechal H., Masala A., Mattern J., McFadyen C., McMahon C., Melegh B., Menovsky T., Morganti-Kossmann C., Mulazzi D., Muraleedharan V., Murray L., Muhlan H., Nair N., Negru A., Nelson D., Newcombe V., Nieboer D., Noirhomme Q., Nyiradi J., Oddo M., Oldenbeuving A., Oresic M., Ortolano F., Palotie A., Parizel P. M., Patruno A., Payen J. -F., Perera N., Perlbarg V., Persona P., Peul W., Piippo-Karjalainen A., Pili F. S., Pirinen M., Ples H., Poca M. A., Pomposo I., Posti J., Puybasset L., Radoi A., Ragauskas A., Raj R., Rambadagalla M., Real R., Rehorcikova V., Rhodes J., Ripatti S., Rocka S., Roe C., Roise O., Roks G., Rosand J., Rosenfeld J., Rosenlund C., Rosenthal G., Rossaint R., Rossi S., Rueckert D., Rusnak M., Sacchi M., Sahakian B., Sahuquillo J., Sakowitz O., Sala F., Sanchez-Porras R., Sandor J., Santos E., Sasu L., Savo D., Schaffer N., Schipper I., Schlosser B., Schmidt S., Schoechl H., Schoonman G., Schou R. F., Schwendenwein E., Scholl M., Sir O., Skandsen T., Smakman L., Smeets D., Smielewski P., Sorinola A., Stamatakis E., Stanworth S., Steinbuchel N., Stevanovic A., Stevens R., Stewart W., Stocchetti N., Sundstrom N., Synnot A., Taccone F. S., Takala R., Tamas V., Tanskanen P., Taylor M. S., Te Ao B., Tenovuo O., Telgmann R., Teodorani G., Theadom A., Thomas M., Tibboel D., Tolias C., Tshibanda J. -F. L., Trapani T., Tudora C. M., Vajkoczy P., Vallance S., Valeinis E., Van der Steen G., van der Jagt M., van der Naalt J., van Dijck J. T. J. M., Van Hecke W., van Heugten C., Van Praag D., Vande Vyvere T., Van Waesberghe J., Vanhaudenhuyse A., Vargiolu A., Vega E., Velt K., Verheyden J., Vespa P. M., Vik A., Vilcinis R., Vizzino G., Vleggeert-Lankamp C., Volovici V., Voormolen D., Vulekovic P., Vamos Z., Wade D., Wang K. K. W., Wang L., Wessels L., Wildschut E., Williams G., Wilson L., Winkler M. K. L., Wolf S., Ylen P., Younsi A., Zaaroor M., Zhihui Y., Ziverte A., Zumbo F., van Essen T. A., van Essen, T, den Boogert, H, Cnossen, M, de Ruiter, G, Haitsma, I, Polinder, S, Steyerberg, E, Menon, D, Maas, A, Lingsma, H, Peul, W, Ackerlund, C, Adams, H, Agnoletti, V, Allanson, J, Amrein, K, Andaluz, N, Andelic, N, Andreassen, L, Antun, A, Anke, A, Antoni, A, Ardon, H, Audibert, G, Auslands, K, Azouvi, P, Azzolini, M, Baciu, C, Badenes, R, Bartels, R, Larizza, D, Barzo, P, Bauerfeind, U, Beauvais, R, Beer, R, Belda, F, Bellander, B, Belli, A, Bellier, R, Benali, H, Benard, T, Berardino, M, Beretta, L, Beynon, C, Bilotta, F, Binder, H, Biqiri, E, Blaabjerg, M, Bouzat, P, Bragge, P, Brazinova, A, Brinck, V, Brooker, J, Brorsson, C, Buki, A, Bullinger, M, Calappi, E, Calvi, M, Cameron, P, Carbayo, L, Carbonara, M, Carise, E, Carpenter, K, Castano-Leon, A, Causin, F, Chevallard, G, Chieregato, A, Citerio, G, Coburn, M, Coles, J, Coles-Kemp, L, Collett, J, Cooper, J, Correia, M, Covic, A, Curry, N, Czeiter, E, Czosnyka, M, Dahyot-Fizelier, C, Damas, F, Damas, P, Dawes, H, De Keyser, V, Della, C, Depreitere, B, Dilvesi, D, Ding, S, Dippel, D, Dixit, A, Donoghue, E, Dreier, J, Duliere, G, Eapen, G, Engemann, H, Ercole, A, Esser, P, Ezer, E, Fabricius, M, Feigin, V, Feng, J, Foks, K, Fossi, F, Francony, G, Freo, U, Frisvold, S, Furmanov, A, Gagliardo, P, Galanaud, D, Gantner, D, Gao, G, Geleijns, K, George, P, Ghuysen, A, Giga, L, Giraud, B, Glocker, B, Golubovic, J, Gomez, P, Grossi, F, Gruen, R, Gupta, D, Haagsma, J, Hartings, J, Helbok, R, Helseth, E, Hertle, D, Hoedemaekers, A, Hoefer, S, Horton, L, Huijben, J, Hutchinson, P, Haberg, A, Jacobs, B, Jankowski, S, Jarrett, M, Jelaca, B, Jiang, J, Jones, K, Kamnitsas, K, Karan, M, Katila, A, Kaukonen, M, Kerforne, T, Kivisaari, R, Kolias, A, Kolumban, B, Kompanje, E, Kolundzija, K, Kondziella, D, Koskinen, L, Kovacs, N, Lagares, A, Lanyon, L, Laureys, S, Lecky, F, Ledig, C, Lefering, R, Legrand, V, Lei, J, Levi, L, Lightfoot, R, Loeckx, D, Lozano, A, Macdonald, S, Maegele, M, Majdan, M, Major, S, Manara, A, Manley, G, Martin, D, Martin, L, Martino, C, Maruenda, A, Marechal, H, Masala, A, Mattern, J, Mcfadyen, C, Mcmahon, C, Melegh, B, Menovsky, T, Morganti-Kossmann, C, Mulazzi, D, Muraleedharan, V, Murray, L, Muhlan, H, Nair, N, Negru, A, Nelson, D, Newcombe, V, Nieboer, D, Noirhomme, Q, Nyiradi, J, Oddo, M, Oldenbeuving, A, Oresic, M, Ortolano, F, Palotie, A, Parizel, P, Patruno, A, Payen, J, Perera, N, Perlbarg, V, Persona, P, Piippo-Karjalainen, A, Pili, F, Pirinen, M, Ples, H, Poca, M, Pomposo, I, Posti, J, Puybasset, L, Radoi, A, Ragauskas, A, Raj, R, Rambadagalla, M, Real, R, Rehorcikova, V, Rhodes, J, Ripatti, S, Rocka, S, Roe, C, Roise, O, Roks, G, Rosand, J, Rosenfeld, J, Rosenlund, C, Rosenthal, G, Rossaint, R, Rossi, S, Rueckert, D, Rusnak, M, Sacchi, M, Sahakian, B, Sahuquillo, J, Sakowitz, O, Sala, F, Sanchez-Porras, R, Sandor, J, Santos, E, Sasu, L, Savo, D, Schaffer, N, Schipper, I, Schlosser, B, Schmidt, S, Schoechl, H, Schoonman, G, Schou, R, Schwendenwein, E, Scholl, M, Sir, O, Skandsen, T, Smakman, L, Smeets, D, Smielewski, P, Sorinola, A, Stamatakis, E, Stanworth, S, Steinbuchel, N, Stevanovic, A, Stevens, R, Stewart, W, Stocchetti, N, Sundstrom, N, Synnot, A, Taccone, F, Takala, R, Tamas, V, Tanskanen, P, Taylor, M, Te Ao, B, Tenovuo, O, Telgmann, R, Teodorani, G, Theadom, A, Thomas, M, Tibboel, D, Tolias, C, Tshibanda, J, Trapani, T, Tudora, C, Vajkoczy, P, Vallance, S, Valeinis, E, Van der Steen, G, van der Jagt, M, van der Naalt, J, van Dijck, J, Van Hecke, W, van Heugten, C, Van Praag, D, Vande Vyvere, T, Van Waesberghe, J, Vanhaudenhuyse, A, Vargiolu, A, Vega, E, Velt, K, Verheyden, J, Vespa, P, Vik, A, Vilcinis, R, Vizzino, G, Vleggeert-Lankamp, C, Volovici, V, Voormolen, D, Vulekovic, P, Vamos, Z, Wade, D, Wang, K, Wang, L, Wessels, L, Wildschut, E, Williams, G, Wilson, L, Winkler, M, Wolf, S, Ylen, P, Younsi, A, Zaaroor, M, Zhihui, Y, Ziverte, A, Zumbo, F, van Essen T. A., den Boogert H. F., Cnossen M. C., de Ruiter G. C. W., Haitsma I., Polinder S., Steyerberg E. W., Menon D., Maas A. I. R., Lingsma H. F., Peul W. C., Ackerlund C., Adams H., Agnoletti V., Allanson J., Amrein K., Andaluz N., Andelic N., Andreassen L., Antun A., Anke A., Antoni A., Ardon H., Audibert G., Auslands K., Azouvi P., Azzolini M. L., Baciu C., Badenes R., Bartels R., Larizza D., Barzo P., Bauerfeind U., Beauvais R., Beer R., Belda F. J., Bellander B. -M., Belli A., Bellier R., Benali H., Benard T., Berardino M., Beretta L., Beynon C., Bilotta F., Binder H., Biqiri E., Blaabjerg M., den Boogert H., Bouzat P., Bragge P., Brazinova A., Brinck V., Brooker J., Brorsson C., Buki A., Bullinger M., Calappi E., Calvi M. R., Cameron P., Carbayo L. G., Carbonara M., Carise E., Carpenter K., Castano-Leon A. M., Causin F., Chevallard G., Chieregato A., Citerio G., Cnossen M., Coburn M., Coles J., Coles-Kemp L., Collett J., Cooper J. D., Correia M., Covic A., Curry N., Czeiter E., Czosnyka M., Dahyot-Fizelier C., Damas F., Damas P., Dawes H., De Keyser V., Della C. F., Depreitere B., Dilvesi D., Ding S., Dippel D., Dixit A., Donoghue E., Dreier J., Duliere G. -L., Eapen G., Engemann H., Ercole A., Esser P., Ezer E., Fabricius M., Feigin V. L., Feng J., Foks K., Fossi F., Francony G., Freo U., Frisvold S., Furmanov A., Gagliardo P., Galanaud D., Gantner D., Gao G., Geleijns K., George P., Ghuysen A., Giga L., Giraud B., Glocker B., Golubovic J., Gomez P. A., Grossi F., Gruen R. L., Gupta D., Haagsma J. A., Hartings J. A., Helbok R., Helseth E., Hertle D., Hoedemaekers A., Hoefer S., Horton L., Huijben J., Hutchinson P. J., Haberg A. K., Jacobs B., Jankowski S., Jarrett M., Jelaca B., Jiang J. -Y., Jones K., Kamnitsas K., Karan M., Katila A., Kaukonen M., Kerforne T., Kivisaari R., Kolias A. G., Kolumban B., Kompanje E., Kolundzija K., Kondziella D., Koskinen L. -O., Kovacs N., Lagares A., Lanyon L., Laureys S., Lecky F., Ledig C., Lefering R., Legrand V., Lei J., Levi L., Lightfoot R., Lingsma H., Loeckx D., Lozano A., MacDonald S., Maegele M., Majdan M., Major S., Manara A., Manley G., Martin D., Martin L. F., Martino C., Maruenda A., Marechal H., Masala A., Mattern J., McFadyen C., McMahon C., Melegh B., Menovsky T., Morganti-Kossmann C., Mulazzi D., Muraleedharan V., Murray L., Muhlan H., Nair N., Negru A., Nelson D., Newcombe V., Nieboer D., Noirhomme Q., Nyiradi J., Oddo M., Oldenbeuving A., Oresic M., Ortolano F., Palotie A., Parizel P. M., Patruno A., Payen J. -F., Perera N., Perlbarg V., Persona P., Peul W., Piippo-Karjalainen A., Pili F. S., Pirinen M., Ples H., Poca M. A., Pomposo I., Posti J., Puybasset L., Radoi A., Ragauskas A., Raj R., Rambadagalla M., Real R., Rehorcikova V., Rhodes J., Ripatti S., Rocka S., Roe C., Roise O., Roks G., Rosand J., Rosenfeld J., Rosenlund C., Rosenthal G., Rossaint R., Rossi S., Rueckert D., Rusnak M., Sacchi M., Sahakian B., Sahuquillo J., Sakowitz O., Sala F., Sanchez-Porras R., Sandor J., Santos E., Sasu L., Savo D., Schaffer N., Schipper I., Schlosser B., Schmidt S., Schoechl H., Schoonman G., Schou R. F., Schwendenwein E., Scholl M., Sir O., Skandsen T., Smakman L., Smeets D., Smielewski P., Sorinola A., Stamatakis E., Stanworth S., Steinbuchel N., Stevanovic A., Stevens R., Stewart W., Stocchetti N., Sundstrom N., Synnot A., Taccone F. S., Takala R., Tamas V., Tanskanen P., Taylor M. S., Te Ao B., Tenovuo O., Telgmann R., Teodorani G., Theadom A., Thomas M., Tibboel D., Tolias C., Tshibanda J. -F. L., Trapani T., Tudora C. M., Vajkoczy P., Vallance S., Valeinis E., Van der Steen G., van der Jagt M., van der Naalt J., van Dijck J. T. J. M., Van Hecke W., van Heugten C., Van Praag D., Vande Vyvere T., Van Waesberghe J., Vanhaudenhuyse A., Vargiolu A., Vega E., Velt K., Verheyden J., Vespa P. M., Vik A., Vilcinis R., Vizzino G., Vleggeert-Lankamp C., Volovici V., Voormolen D., Vulekovic P., Vamos Z., Wade D., Wang K. K. W., Wang L., Wessels L., Wildschut E., Williams G., Wilson L., Winkler M. K. L., Wolf S., Ylen P., Younsi A., Zaaroor M., Zhihui Y., Ziverte A., and Zumbo F.
- Abstract
The names of themembers of the IOPSMS study Group was inverted in the original paper and is now corrected in this article.
- Published
- 2019
4. Utility of breast ultrasonography in the diagnostic work-up of precocious puberty and proposal of a prognostic index for identifying girls with rapidly progressive central precocious puberty
- Author
-
CALCATERRA, V., SAMPAOLO, P., KLERSY, C., LARIZZA, D., ALFEI, A., BRIZZI, V., BENEVENTI, F., and CISTERNINO, M.
- Published
- 2009
5. Pelvic ultrasound evaluation in patients with Turner syndrome during treatment with growth hormone
- Author
-
SAMPAOLO, P., CALCATERRA, V., KLERSY, C., ALFEI, A., DE LEONARDIS, C., MAINO, M., and LARIZZA, D.
- Published
- 2003
- Full Text
- View/download PDF
6. Final Height of Patients with Turner’s Syndrome Treated with Growth Hormone (GH): Indications for GH Therapy Alone at High Doses and Late Estrogen Therapy
- Author
-
Cacciari E., Mazzanti L., Bergamaschi R., Perri A., Scarano E., Chiumello G., Guarnieri M. P., Rigon F., Licersi A., Pasquino A. M., Pucarelli I., Di Maio S., Severi F., Larizza D., Bernasconi S., Buzi F., Matarazzo P., Cavallo L., Saggese G., Tonini G., Sposito M., Gabrielli O., Radetti G., De Luca F., Borrelli P., Morabito F., Bona G., SALERNO, MARIACAROLINA, Cacciari, E., Mazzanti, L., Bergamaschi, R., Perri, A., Scarano, E., Chiumello, G., Guarnieri, M. P., Rigon, F., Licersi, A., Pasquino, A. M., Pucarelli, I., Di Maio, S., Salerno, Mariacarolina, Severi, F., Larizza, D., Bernasconi, S., Buzi, F., Matarazzo, P., Cavallo, L., Saggese, G., Tonini, G., Sposito, M., Gabrielli, O., Radetti, G., De Luca, F., Borrelli, P., Morabito, F., and Bona, G.
- Subjects
medicine.medical_specialty ,Chemotherapy ,Gonad ,medicine.drug_class ,business.industry ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Final height, Turner's syndrome, growth hormone, GH therapy, estrogen therapy, Italian Study Group for Turner Syndrome ,Biochemistry (medical) ,Clinical Biochemistry ,Oxandrolone ,medicine.disease ,Biochemistry ,Group A ,Endocrinology ,medicine.anatomical_structure ,El Niño ,Estrogen ,Internal medicine ,Turner syndrome ,medicine ,Menarche ,business ,medicine.drug - Abstract
We report final height data of patients with Turner's syndrome collected by the Italian Study Group for Turner's Syndrome. One hundred and thirty-five patients reached their final height during GH therapy with different therapeutic regimens (dose and combination). They were divided into 3 groups: group A, 74 patients with high doses of GH (1 IU/kg/week) for at least 2 yr; group A1, GH alone and estrogen therapy added not before 14 yr of chronological age (47 patients, of whom 30 were treated for >4 yr and 10 for >6 yr); group A2, GH plus ethinyl estradiol (17 patients) or GH plus oxandrolone (10 patients); group B, 51 patients with low doses of GH (0.5 IU/kg-week) and high doses of GH for less than 2 yr; and group C, 10 patients with high doses of GH with spontaneous menarche. In contrast to the patients of groups B and C, the patients of group A showed a significantly higher final height (mean, 147.5+/-6.5 cm) than their projected height (mean, 142.9+/-6.4 cm). They showed also a significantly higher final height compared to the subjects of groups B (mean, 145.6+/-5.7 cm) and C (mean, 143.0+/-5.3). Among the patients of group A, the best results were obtained in the patients of group A1 treated with GH alone at high doses and for a longer period (4 yr, 149.3+/-6.4 cm; 6 yr, 153.8+/-4.0 cm). Karyotype, GH secretion, and birth weight did not influence the efficacy of GH therapy. A low target height and a high prevalence of a spontaneous ovarian activity or menarche may negatively influence the effect of GH therapy. Estrogens did not improve final height when added to GH therapy. The use of small doses of oxandrolone was not effective in our experience. GH therapy provides a satisfactory auxological result, especially with high doses of GH alone, given for a long period of time. Optimization of the treatment would seem to require the identification of the ideal age for starting therapy, and this is only possible with a specially designed multicenter study.
- Published
- 1999
- Full Text
- View/download PDF
7. Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study
- Author
-
Cherubini, V, Pintaudi, B, Rossi, Mc, Lucisano, G, Pellegrini, F, Chiumello, G, Frongia, Ap, Monciotti, C, Patera, Ip, Toni, S, Zucchini, S, Nicolucci, A, Lera, R, Iannilli, A, Giorgetti, C, Cesaretti, A, Paparusso, Am, Alessandrelli, Mc, Scipione, M, Balsamo, C, Gallo, F, Lo Presti, D, Passanisi, S, Tumini, S, Cipriano, P, Lazzaro, N, Vergerio, A, Banin, P, Lenzi, L, Coccioli, Ms, D'Annunzio, G, Bruzzese, M, Lombardo, F, Salzano, G, Bonfanti, R, Frontino, G, Battaglino, R, Iughetti, Lorenzo, Predieri, Barbara, Cadario, F, Savastio, S, Zabadneh, N, Zanella, C, Mozzo, E, Tiozzo, S, Benevento, D, Calcaterra, V, Larizza, D, Delvecchio, M, Trada, M, Rabbone, I, Sicignano, S, Cauvin, V, Franceschi, R, Gargantini, L, Pennati, C, Bianchi, G, Salvatoni, A, Maffeis, C, Marigliano, M, Sabbion, A, Arnaldi, C, Tosini, D, Tossi, Mc, Valentini, M, D'Alonzo, D, Pirozzoli, C, Di Nardo, B, Memmo, R, and Cianci, A.
- Subjects
Male ,medicine.medical_specialty ,Children and adolescents ,endocrine system diseases ,Adolescent ,Endocrinology, Diabetes and Metabolism ,medicine.medical_treatment ,Insulin, Isophane ,Medicine (miscellaneous) ,NPH insulin ,TYPE I (INSULIN-DEPENDENT) DIABETES MELLITUS ,Internal medicine ,Diabetes mellitus ,medicine ,Humans ,Hypoglycemic Agents ,Insulin ,Child ,Retrospective Studies ,Glycated Hemoglobin ,Type 1 diabetes ,Severe hypoglycemia ,Nutrition and Dietetics ,business.industry ,Incidence (epidemiology) ,Incidence ,Infant ,Retrospective cohort study ,Diabetes ketoacidosis ,Ketosis ,medicine.disease ,Hypoglycemia ,Ketoacidosis ,Surgery ,Diabetes Mellitus, Type 1 ,Italy ,Child, Preschool ,Regular insulin ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and aims: Evaluation of incidence and correlates of severe hypoglycemia (SH) and diabetes ketoacidosis (DKA) in children and adolescents with T1DM. Methods and results: Retrospective study conducted in 29 diabetes centers from November 2011 to April 2012. The incidence of SH and DKA episodes and their correlates were assessed through a questionnaire administered to parents of patients aged 0e18 years. Incidence rates and incident rate ratios (IRRs) were estimated through multivariate Poisson regression analysis and multilevel analysis. Overall, 2025 patients were included (age 12.4 � 3.8 years; 53% males; diabetes dura- tion 5.6 � 3.5 years; HbA1c 7.9 � 1.1%). The incidence of SH and DKA were of 7.7 and 2.4 events/ 100 py, respectively. The risk of SH was higher in females (IRR Z 1.44; 95%CI 1.04e1.99), in pa- tients using rapid acting analogues as compared to regular insulin (IRR Z 1.48; 95%CI 0.97e2.26) and lower for patients using long acting analogues as compared to NPH insulin (IRR Z 0.40; 95% CI 0.19e0.85). No correlations were found between SH and HbA1c levels. The risk of DKA was higher in patients using rapid acting analogues (IRR Z 4.25; 95%CI 1.01e17.86) and increased with insulin units needed (IRR Z 7.66; 95%CI 2.83e20.74) and HbA1c levels (IRR Z 1.63; 95% CI 1.36e1.95). Mother' sa ge was inversely associated with the risk of both SH (IRRZ 0.95; 95%CI 0.92e0.98) and DKA (IRR Z 0.94; 95%CI 0.88e0.99). When accounting for center effect, the risk of SH associated with the use of rapid acting insulin analogues was attenuated (IRR Z 1.48; 95%CI 0.97e2.26); 33% and 16% of the residual variance in SH and DKA risk was ex- plained by center effect. Conclusion: The risk of SH and DKA is mainly associated with treatment modalities and strongly depends on the practice of specialist centers.
- Published
- 2014
8. New understandings of the genetic basis of isolated idiopathic central hypogonadism
- Author
-
Bonomi, M, Libri, Dv, Guizzardi, F, Guarducci, E, Maiolo, E, Pignatti, E, Asci, R, Persani, L, Idiopathic Central Hypogonadism Study Group of the Italian Societies of Endocrinology, Pediatric, Endocrinology, Diabetes Aimaretti, G, Altobelli, M, Arnaldi, G, Baldi, M, Bartalena, L, Beccaria, L, Beck Peccoz, P, Bellastella, G, Borretta, G, Buzi, F, Cannavo', Salvatore, Cappa, M, Cariboni, A, Ciampani, T, Cicognani, A, Cisternino, M, Corbetta, S, Corciulo, N, Cozzi, R, D'Elia, Av, Uberti, Ed, De Marchi, M, Forti, G, di Iorgi, N, Fabbri, A, Ferlin, A, Gaudino, R, Grosso, E, Krausz, C, Lanfranco, F, Larizza, D, Limone, P, Maggi, M, Maggi, R, Maghnie, M, Mancini, A, Mandrile, G, Marino, M, Mencarelli, Ma, Migone, N, Neri, G, Perroni, L, Pilotta, A, Pincelli, Ai, Pizzocaro, A, Pontecorvi, A, Radetti, G, Razzore, P, Russo, G, Salvini, F, Secco, A, Segni, M, Simoni, M, Sinisi, A, Vigneri, R, and Weber, G.
- Subjects
Male ,Infertility ,central hypogonadism ,congenital hypogonadism ,GnRH ,hypogonadotropic hypogonadism ,hypothalamus–pituitary–gonadal axis ,Kallmann syndrome ,male infertility ,Hypothalamo-Hypophyseal System ,medicine.medical_specialty ,Urology ,Context (language use) ,Review ,Disease ,Bioinformatics ,Male infertility ,Mice ,Hypogonadotropic hypogonadism ,Internal medicine ,medicine ,Animals ,Humans ,Animals, Humans, Hypogonadism ,complications/genetics/physiopathology, Hypothalamo-Hypophyseal System ,physiopathology, Infertility ,genetics, Italy, Kallmann Syndrome ,complications/genetics, Male, Mice, Mice ,Knockout, Models ,Animal ,cardiovascular diseases ,Infertility, Male ,Mice, Knockout ,business.industry ,Hypogonadism ,General Medicine ,medicine.disease ,Penetrance ,nervous system diseases ,Endocrinology ,Italy ,Models, Animal ,central hypogonadism, congenital hypogonadism, GnRH, hypogonadotropic hypogonadism, hypothalamus–pituitary–gonadal axis, Kallmann syndrome, male infertility ,business ,gnrh ,hypothalamus-pituitary-gonadal axis ,kallmann syndrome ,Rare disease - Abstract
Idiopathic hypogonadotropic hypogonadism is a rare disease that is characterized by delayed/absent puberty and/or infertility due to an insufficient stimulation of an otherwise normal pituitary–gonadal axis by gonadotrophin-releasing hormone (GnRH) action. Because reduced or normal luteinizing hormone (LH)/follicle-stimulating hormone (FSH) levels may be observed in the affected patients, the term idiopathic central hypogonadism (ICH) appears to be more appropriate. This disease should be distinguished from central hypogonadism that is combined with other pituitary deficiencies. Isolated ICH has a complex pathogenesis and is fivefold more prevalent in males. ICH frequently appears in a sporadic form, but several familial cases have also been reported. This finding, in conjunction with the description of numerous pathogenetic gene variants and the generation of several knockout models, supports the existence of a strong genetic component. ICH may be associated with several morphogenetic abnormalities, which include osmic defects that, with ICH, constitute the cardinal manifestations of Kallmann syndrome (KS). KS accounts for approximately 40% of the total ICH cases and has been generally considered to be a distinct subgroup. However, the description of several pedigrees, which include relatives who are affected either with isolated osmic defects, KS, or normo-osmic ICH (nICH), justifies the emerging idea that ICH is a complex genetic disease that is characterized by variable expressivity and penetrance. In this context, either multiple gene variants or environmental factors and epigenetic modifications may contribute to the variable disease manifestations. We review the genetic mechanisms that are presently known to be involved in ICH pathogenesis and provide a clinical overview of the 227 cases that have been collected by the collaborating centres of the Italian ICH Network.
- Published
- 2012
9. The osteopontin gene +1239A/C single nucleotide polymorphism is associated with type 1 diabetes mellitus in the Italian population
- Author
-
Chiocchetti, A., Orilieri, E., Cappellano, G., Barizzone, N., D Alfonso, S., D Annunzio, G., Lorini, R., Ravazzolo, R., Cadario, F., Martinetti, M., Calcaterra, V., Cerutti, F., Graziella BRUNO, Larizza, D., and Dianzani, U.
- Subjects
Male ,medicine.medical_specialty ,Adolescent ,Immunology ,Single-nucleotide polymorphism ,Polymorphism, Single Nucleotide ,HLA-DQ alpha-Chains ,Proinflammatory cytokine ,HLA-DQ Antigens ,Internal medicine ,Diabetes mellitus ,medicine ,Genetic predisposition ,HLA-DQ beta-Chains ,Humans ,Immunology and Allergy ,Genetic Predisposition to Disease ,Osteopontin ,Child ,Pharmacology ,Genetics ,Type 1 diabetes ,biology ,business.industry ,Multiple sclerosis ,medicine.disease ,Diabetes Mellitus, Type 1 ,Endocrinology ,biology.protein ,Female ,Protein Multimerization ,business ,TCF7L2 ,Genome-Wide Association Study - Abstract
Secreted phosphoprotein 1, also known as Osteopontin (Opn), is a proinflammatory cytokine involved in the TH1 response and is highly expressed in the islets and pancreatic lymph nodes of non-obese diabetic mice before the onset of diabetes. In humans, typing of the +1239A/C single nucleotide polymorphism (SNP) in the 3'UTR of the Opn gene (SPP1) showed that +1239C carriers displayed higher Opn serum levels than +1239A homozygotes and a higher risk of developing autoimmune/lymphoproliferative syndrome, multiple sclerosis, and systemic lupus erythematosus. The aim of this work is to evaluate whether +1239A/C is also associated with type 1 diabetes mellitus (T1DM). We typed +1239A/C in an initial cohort of 184 T1DM patients and 361 controls, and confirmed our data in a second cohort of 513 patients and 857 controls. In both cohorts, +1239C carriers displayed a significantly higher risk of T1DM than +1239A homozygotes (combined cohorts: OR=1.63, 95%CI: 1.34–1.97). Clinical analysis did not detect any differences between patients carrying or not +1239C in terms of gender distribution and age at T1DM diagnosis. These data suggest that SPP1 variants marked by +1239C are associated with T1DM development in the Italian population. The predisposing effect may depend on its effect on Opn levels.
- Published
- 2010
10. A large-scale association study to assess the impact of known variants of the human INHA gene on premature ovarian failure
- Author
-
Corre, T., Schuettler, J., Bione, S., Marozzi, A., Persani, L., Rossetti, R., Torricelli, F., Giotti, I., Vogt, P., Toniolo, D., Italian Network for the study of Ovarian Dysfunctions, Biondi, M, Bruni, V, Brigante, C, Cisternino, M, Colombo, I, Crosignani, Pg, D'Avanzo, Mg, Dalprà, L, Danesino, C, Di Prospero, F, Donti, E, Falorni, A, Fusi, F, Lanzi, R, Larizza, D, Locatelli, N, Madaschi, S, Maghnie, M, Marzotti, S, Migone, N, Nappi, R, Palli, D, Patricelli, Mg, Pisani, C, Prontera, P, Petraglia, F, Renieri, Alessandra, Ricca, I, Ripamonti, A, Russo, G, Russo, S, Tibiletti, Mg, Tonacchera, M, Vegetti, W, Villa, N, Vineis, P, and Zuffardi, O.
- Subjects
Adult ,Adolescent ,endocrine system diseases ,Genome-wide association study ,Primary Ovarian Insufficiency ,premature ovarian failure ,Biology ,Polymorphism, Single Nucleotide ,inhibin variants ,Cohort Studies ,Gene Frequency ,Polymorphism (computer science) ,medicine ,Humans ,Inhibins ,Allele ,Risk factor ,Child ,Allele frequency ,Gene ,Genetics ,INHA ,Rehabilitation ,genetic risk factor ,Obstetrics and Gynecology ,Middle Aged ,medicine.disease ,female genital diseases and pregnancy complications ,Premature ovarian failure ,infertility ,Reproductive Medicine ,Female ,Genome-Wide Association Study - Abstract
Background Three variants of the human INHA gene have been reported to be associated with premature ovarian failure (POF) in case-control studies involving a small number of patients and controls. Since inhibin has a fundamental role in the control of ovarian function, it is important to establish the relevance of the reported variants for disease risk. Methods Three independent POF cohorts, recruited in Northern and Central Italy and in Germany consisting of a total of 611 patients and 1084 matched controls, were genotyped for the three variants: -16C > T, -124A > G and 769G > A. Results No significant difference was detected between allelic frequencies of the INHA promoter variants between POF patients and controls. The rare allele in the coding variant appeared to be more frequent among the control populations. Conclusions The association between the INHA promoter variants and POF could not be replicated, and our results suggest that this discrepancy is likely to be due to the small sample size of previous studies. The rare allele of the coding variant seems to exert a protective effect against loss of ovarian function, which should be confirmed in additional large and ethnically diverse cohorts.
- Published
- 2009
11. Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome
- Author
-
Castronovo, C., primary, Rossetti, R., additional, Rusconi, D., additional, Recalcati, M. P., additional, Cacciatore, C., additional, Beccaria, E., additional, Calcaterra, V., additional, Invernizzi, P., additional, Larizza, D., additional, Finelli, P., additional, and Persani, L., additional
- Published
- 2013
- Full Text
- View/download PDF
12. Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene.
- Author
-
Rinne, T.K., Spadoni, E., Kjaer, K.W., Danesino, C., Larizza, D., Kock, M. de, Huoponen, K., Savontaus, M.L., Aaltonen, M., Duijf, P.H., Brunner, H.G., Penttinen, M., Bokhoven, J.H.L.M. van, Rinne, T.K., Spadoni, E., Kjaer, K.W., Danesino, C., Larizza, D., Kock, M. de, Huoponen, K., Savontaus, M.L., Aaltonen, M., Duijf, P.H., Brunner, H.G., Penttinen, M., and Bokhoven, J.H.L.M. van
- Abstract
Contains fulltext : 51135.pdf (publisher's version ) (Closed access), The ADULT syndrome (Acro-Dermato-Ungual-Lacrimal-Tooth, OMIM 103285) is a rare ectodermal dysplasia associated with limb malformations and caused by heterozygous mutations in p63. ADULT syndrome has clinical overlap with other p63 mutation syndromes, such as EEC (OMIM 604292), LMS (OMIM 603543), AEC (106260), RHS (129400) and SHFM4 (605289). ADULT syndrome characteristics are ectrodactyly, ectodermal dysplasia, mammary gland hypoplasia and normal lip and palate. The latter findings allow differentiation from EEC syndrome. LMS differs by milder ectodermal involvement. Here, we report three new unrelated ADULT syndrome families, all with mutations of arginine 298. On basis of 16 patients in five families with R298 mutation, we delineate the ADULT syndrome phenotype. In addition, we have documented a gain-of-function effect on the dNp63gamma isoform caused by this mutation. We discuss the possible relevance of oral squamous cell carcinoma in one patient, who carries this p63 germline mutation.
- Published
- 2006
13. Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene
- Author
-
Rinne, T., Spadoni, E., Kjær, Klaus Wilbrandt, Danesino, C., Larizza, D., Kock, M., Huoponen, K., Savontaus, M.L., Aaltonen, M., Duijf, P., Brunner, H.G., Penttinen, M., Bokhoven, H. van, Rinne, T., Spadoni, E., Kjær, Klaus Wilbrandt, Danesino, C., Larizza, D., Kock, M., Huoponen, K., Savontaus, M.L., Aaltonen, M., Duijf, P., Brunner, H.G., Penttinen, M., and Bokhoven, H. van
- Abstract
Udgivelsesdato: 2006/8
- Published
- 2006
14. Targeting the Immunogenetic Diseases with the Appropriate HLA Molecular Typing: Critical Appraisal on 2666 Patients Typed in One Single Centre
- Author
-
Guarene, M., primary, Capittini, C., additional, De Silvestri, A., additional, Pasi, A., additional, Badulli, C., additional, Sbarsi, I., additional, Cremaschi, A. L., additional, Garlaschelli, F., additional, Pizzochero, C., additional, Monti, M. C., additional, Montecucco, C., additional, Corazza, G. R., additional, Larizza, D., additional, Bianchi, P. E., additional, Salvaneschi, L., additional, and Martinetti, M., additional
- Published
- 2013
- Full Text
- View/download PDF
15. GROWTH HORMONE TREATMENT AND SHBG LEVELS IN TURNER SYNDROME
- Author
-
Municchi, C, primary, Pasquino, A M, additional, Larizza, D, additional, Balducci, R, additional, Passeri, K, additional, Pucarelli, I, additional, and Toscano, V, additional
- Published
- 1994
- Full Text
- View/download PDF
16. EFFECTS OF CONTINUOUS GHRH INFUSION ON GH SECRETION IN GH-DEFICIENT PATIENTS WITH HYPOTHALAMIC-PITUITARY ABNORMALITIES
- Author
-
Maghnie, M, primary, Moretta, A, additional, Valtorta, A, additional, Preti, P, additional, Palladini, G, additional, Zuliani, I, additional, Larizza, D, additional, and Severi, F, additional
- Published
- 1993
- Full Text
- View/download PDF
17. GROWTH HORMONE AND ESTROGENS IN PATIENTS WITH TURNER SYNDROME: IN VIVO AND IN VITRO STUDIES
- Author
-
Larizza, D, primary, Barreca, A, additional, Ponzani, P, additional, Damonte, G, additional, Curto, F Lo, additional, Minuto, F, additional, Severi, F, additional, and Giordano, G, additional
- Published
- 1993
- Full Text
- View/download PDF
18. Excess of HLA parental sharing in families with Turner patients
- Author
-
Cuccia, M., primary, Martinetti, M., additional, Larizza, D., additional, Bolis, P. F., additional, and Severi, F., additional
- Published
- 1990
- Full Text
- View/download PDF
19. Poland's syndrome associated with growth hormone deficiency.
- Author
-
Larizza, D, primary and Maghnie, M, additional
- Published
- 1990
- Full Text
- View/download PDF
20. MOLECULAR ANALYSIS OF CYP21 GENE MUTATIONS CARRIED ON HLA-B14 POSITIVE HAPLOTYPES.
- Author
-
Dondi, E., Cuccia, M., Keller, E., Martinetti, M., Larizza, D., and Albert, E. D.
- Published
- 1994
- Full Text
- View/download PDF
21. Thyroid volume is progressively reduced as a sequela of neck irradiation for childhood Hodgkin's disease
- Author
-
Bossi, G., Larizza, D., Sommaruga, G., Corbella, F., Klersy, C., and Maurizio Arico'
- Subjects
Male ,Adolescent ,Radiotherapy ,Thyroid Gland ,Infant ,Thyroid Function Tests ,Combined Modality Therapy ,Hodgkin Disease ,Hypothyroidism ,Child, Preschool ,Antineoplastic Combined Chemotherapy Protocols ,Humans ,Female ,Atrophy ,Child ,Radiation Injuries ,Neck - Abstract
Thyroid volume reduction was observed, among 25 subjects off-therapy after Hodgkin's disease. The volume reduction was related to dose (p = 0.014) and time from radiotherapy (p = 0.01). The correlation was very specific since all patients with reduced volume had hypothyroidism, but not very sensitive since 25% of subjects with thyroid dysfunction had normal gland volume.
22. [Hyperthyroidism in children (author's transl)]
- Author
-
Lorini R, Larizza D, Bozzola M, Livieri C, Cisternino M, Alessandro Salvatoni, and Severi F
- Subjects
Male ,Thyroiditis ,Methimazole ,Adolescent ,Goiter ,Hyperthyroidism ,Propranolol ,Graves Disease ,Iodine Radioisotopes ,Antithyroid Agents ,Propylthiouracil ,Child, Preschool ,Thyroidectomy ,Humans ,Female ,Child - Abstract
The present paper analyzes the causes, signs and symptoms of hyperthyroidism in children and the problems, complications and results associated with the various therapeutic regimes. Childhood hyperthyroidism is usually due to Grave's disease, an autoimmune thyroid disease. Genetic factors are also involved in its development. The diagnosis and in particular the differential diagnosis with Hashimoto's thyroiditis are discussed. Treatment of Graves' disease is controversial, but medical therapy is commonly accepted as the treatment of choice. Some dosage schedules of antithyroid drugs are considered, and some techniques for predicting remission status and relapse of disease are reported. Both the minor and more serious complications of medical therapy are examined. Careful follow-up for the development of hypothyroidism is advocated, especially in patients treated with radiation or surgery. Autonomous hyperfunctioning thyroid adenoma is rare, but occurs even in childhood, and can degenerate into carcinoma.
23. Younger age at diagnosis of type 1 diabetes mellitus in children of immigrated families born in Italy
- Author
-
Cadario, F., Vercellotti, A., Trada, M., Zaffaroni, M., Rapa, A., Iafusco, D., Salardi, S., Baldelli, R., Bona, G., Rigardo, S., Lera, R., Cherubini, V., Francolini, S., Fifi, A., Scaramuzza, A., Cavallo, L., Zucchini, S., Corbelli, E., Gallo, F., Zedda, M. A., Angius, E., Ripoli, C., La Loggia, A., Scalia, G., Cicchetti, M., Macchiaroli, A., Oteri, F., Pocecco, M., Cerasoli, G., Sperlì, D., Montaldo, M., Startari, L., Vergerio, A., Banin, P., Martinucci, M., Toni, S., Mastrangelo, C., Lorini, R., D Annunzio, G., Cotellessa, M., Minicucci, L., Pescarmona, M., Di Quinci, M., Lombardo, F., Iughetti, L., Predieri, B., Boccato, S., Prisco, F., Mongiotti, C., Cardella, F., Vanelli, M., Chiari, G., Zanasi, P., Larizza, D., Borghesi, A., Giorgi, G., Calisti, L., Menchini, S., Marsciani, A., Pausini, L., Patera, P., Crinò, A., Cerutti, F., Sacchetti, C., Rabbone, I., Fontana, F., Giorgetti, R., Trussi, G., Cauvin, V., Gargantini, L., Tenore, A., Zanatta, M., Alessandro Salvatoni, Fusari, M., Araldi, C., Cadario F, Vercellotti A, Trada M, Zaffaroni M, Rapa A, Iafusco D, Salardi S, Baldelli R, Bona G, Diabetes Study Group of the Italian Society for Pediatric Endocrinology and Diabetology., Cadario, F, Vercellotti, A, Trada, M, Zaffaroni, M, Rapa, A, Iafusco, Dario, Salardi, S, Baldelli, R, Bona, G, DIABETES STUDY GROUP OF THE ITALIAN SOCIETY FOR, Pediatric, and ENDOCRINOLOGY AND, Diabetology
- Subjects
Male ,Pediatrics ,medicine.medical_specialty ,Younger age ,Endocrinology, Diabetes and Metabolism ,media_common.quotation_subject ,Immigration ,Age at diagnosis ,Developing country ,TYPE 1 DIABETES MELLITUS ,Developing countries ,Endocrinology ,Accelerator hypothesis ,Risk Factors ,EPIDEMIOLOGY ,Humans ,Medicine ,media_common.cataloged_instance ,Age of Onset ,European union ,Child ,Developing Countries ,media_common ,Type 1 diabetes ,business.industry ,Pediatric diabetes ,IMMIGRATED CHILDREN ,Hygiene hypothesis ,Emigration and Immigration ,medicine.disease ,Diabetes Mellitus, Type 1 ,Italy ,Child, Preschool ,Cohort ,Female ,business - Abstract
The aim of this study was to evaluate the age of immigrants' children at diagnosis of Type 1 diabetes (T1DM) according to their country of birth. Immigration from developing countries to a westernised area causes rapid changes in the environmental conditions, and we investigated whether the location of birth, either inside or outside Italy, is associated with age at diagnosis of diabetes. Out of a prevalent hospital-based cohort of 5718 T1DM children cared for in 2002 in 47 Italian Pediatric Diabetes Units, we recruited 195 children (M: 97) of immigrants from developing countries--119 were born in Italy and 76 outside the European Union. Children with only one immigrant parent (no. 42) were also included. Age at diagnosis of T1DM, and other variables were compared with those of Italian children. Children of immigrated families born in Italy developed T1DM at a median age of 4.0 yr (IQR 2.2-6.9), whereas those born in developing countries and that had immigrated to Italy after birth developed T1DM at a median age of 7.9 yr (IQR 5.1-10.7, p < 0.001). Among the children born in Italy, 77 had parents who were both immigrants and the children's median age at diagnosis was 3.8 yr (IQR 2.1-6.3); 42 had only one immigrant parent and, when it was the father (no. = 23), median age was even younger (2.9 yr, IQR 2.0-8.2). Ten children had immigrated in their first yr of life and their median age was 9.1 yr (IQR 5.0-10.6). The median age of the Italian children was 6.6 yr (IQR 3.6-9.5). Results show that the outbreak of T1DM is earlier in immigrants' children born in Italy than in original countries.
24. EFFECTS OF CONTINUOUS GHRH INFUSION ON GH SECRETION IN GHDEFICIENT PATIENTS WITH HYPOTHALAMICPITUITARY ABNORMALITIES
- Author
-
Maqhnie, M., Moretta, A., Valtorta, A., Preti, P., Palladini, G., Zuliani, I., Larizza, D., and Severi, F.
- Published
- 1993
25. Prevalence of activating thyrotropin receptor and gsa gene mutations in paediatric thyroid toxic adenomas: a multicentric italian study
- Author
-
Valeria Calcaterra, G. De Marco, Massimo Tonacchera, Maria Rosa Pelizzo, Maria Segni, Graziano Cesaretti, E. Ferrarini, Giovanna Weber, Daniela Larizza, C. Di Cosmo, Paolo Vitti, Patrizia Agretti, Andrea Corrias, Agretti, P, Segni, M, De Marco, G, Ferrarini, E, Di Cosmo, C, Corrias, A, Weber, Giovanna, Larizza, D, Calcaterra, V, Pelizzo, Mr, Cesaretti, G, Vitti, P, and Tonacchera, M.
- Subjects
medicine.medical_specialty ,Gs alpha subunit ,Adolescent ,Endocrinology, Diabetes and Metabolism ,Thyrotropin ,Child ,Child, Preschool ,GTP-Binding Protein alpha Subunits, Gs ,Humans ,Mutation ,Receptors, Thyrotropin ,Thyroid Neoplasms ,Gene mutation ,medicine.disease_cause ,Thyrotropin receptor ,Gs ,Endocrinology ,Internal medicine ,Receptors ,medicine ,Preschool ,business.industry ,Thyroid ,GTP-Binding Protein alpha Subunits ,Diabetes and Metabolism ,medicine.anatomical_structure ,business - Published
- 2013
26. Efficacy and safety of growth hormone treatment in children with short stature: the Italian cohort of the GeNeSIS clinical study
- Author
-
Cappa, M., Iughetti, L., Loche, S., Maghnie, M., Vottero, A, GeNeSIS National Board on behalf of the GeNeSIS Italian Investigators, Franco, Antoniazzi, Luciano, Beccaria, Sergio, Bernasconi, Domenico, Caggiano, Manuela, Caruso-Nicoletti, Alessandra, Catucci, Francesco, Chiarelli, Stefano, Cianfarani, Annarita, Colucci, Francesca De Rienzo, Raffaele Di Pumpo, Alessandra Di Stasio, Giovanni, Farello, Leonardo, Felici, Pasquale, Femiano, Luigi, Garagantini, Claudia, Giavoli, Nellaaugusta, Greggio, Laura, Guazzarotti, Daniela, Larizza, Mariarosaria, Licenziati, Antonella, Lonero, Mariacristina, Maggio, Alberto, Marsciani, Patrizia, Matarazzo, Laura, Mazzanti, Beatrice, Messini, Flavia, Napoli, Annamaria, Pasquino, Laura, Perrone, Sabrina, Pilia, Alba, Pilotta, Marzia, Piran, Gabriella, Pozzobon, Predieri, Barbara, Michele, Sacco, Mariacarolina, Salerno, Antonina, Tirendi, Graziamaria, Ubertini, Silvia, Vannelli, Malgorzata, Wasniewska, Maria, Zampolli, Martina, Zanotti, Gianvincenzo, Zuccotti, Cappa, M., Iughetti, L., Loche, S., Maghnie, M., Vottero, A, Salerno, Mariacarolina, Vottero, A.* Antoniazzi F, Beccaria L, Bernasconi S, Caggiano D, Caruso-Nicoletti M, Catucci A, Chiarelli F, Cianfarani S, Colucci AR, De Rienzo F, Di Pumpo R, Di Stasio A, Farello G, Felici L, Femiano P, Garagantini L, Giavoli C, Greggio NA, Guazzarotti L, Larizza D, Licenziati MR, Lonero A, Maggio MC, Marsciani A, Matarazzo P, Mazzanti L, Messini B, Napoli F, Pasquino AM, Perrone L, Pilia S, Pilotta A, Piran M, Pozzobon G, Predieri B, Sacco M, Salerno M, Tirendi A, Ubertini G, Vannelli S, Wasniewska M, Zampolli M, Zanotti M, Zuccotti G, Vottero, A., and Perrone, Laura
- Subjects
Male ,Pediatrics ,Endocrinology, Diabetes and Metabolism ,Turner Syndrome ,Pediatric GH treatment ,Growth ,Clinical study ,0302 clinical medicine ,Endocrinology ,Turner syndrome ,030212 general & internal medicine ,Prospective Studies ,Prospective cohort study ,Child ,Final height ,Safety ,Short stature ,Human Growth Hormone ,Diabetes and Metabolism ,Growth hormone treatment ,Treatment Outcome ,Italy ,Child, Preschool ,Cohort ,Original Article ,Female ,Patient Safety ,medicine.symptom ,Human ,medicine.medical_specialty ,Adolescent ,030209 endocrinology & metabolism ,Dwarfism ,Neuroendocrinology ,Body Height ,Dwarfism, Pituitary ,Humans ,03 medical and health sciences ,medicine ,Preschool ,business.industry ,medicine.disease ,Prospective Studie ,Pituitary ,Observational study ,Final height, Growth, Pediatric GH treatment, Safety, Short stature, Endocrinology, Diabetes and Metabolism, Endocrinology ,business - Abstract
Purpose: We examined auxological changes in growth hormone (GH)-treated children in Italy using data from the Italian cohort of the multinational observational Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) of pediatric patients requiring GH treatment. Methods: We studied 711 children (median baseline age 9.6 years). Diagnosis associated with short stature was as determined by the investigator. Height standard deviation score (SDS) was evaluated yearly until final or near-final height (n = 78). Adverse events were assessed in all GH-treated patients. Results: The diagnosis resulting in GH treatment was GH deficiency (GHD) in 85.5 % of patients, followed by Turner syndrome (TS 6.6 %). Median starting GH dose was higher in patients with TS (0.30 mg/kg/week) than patients with GHD (0.23 mg/kg/week). Median (interquartile range) GH treatment duration was 2.6 (0.6â3.7) years. Mean (95 % confidence interval) final height SDS gain was 2.00 (1.27â2.73) for patients with organic GHD (n = 18) and 1.19 (0.97â1.40) for patients with idiopathic GHD (n = 41), but lower for patients with TS, 0.37 (â0.03 to 0.77, n = 13). Final height SDS was >â2 for 94 % of organic GHD, 88 % of idiopathic GHD and 62 % of TS patients. Mean age at GH start was lower for organic GHD patients, and treatment duration was longer than for other groups, resulting in greater mean final height gain. GH-related adverse events occurred mainly in patients diagnosed with idiopathic GHD. Conclusions: Data from the Italian cohort of GeNeSIS showed auxological changes and safety of GH therapy consistent with results from international surveillance databases.
- Full Text
- View/download PDF
27. Gender Differences at the Onset of Autoimmune Thyroid Diseases in Children and Adolescents.
- Author
-
Calcaterra V, Nappi RE, Regalbuto C, De Silvestri A, Incardona A, Amariti R, Bassanese F, Clemente AM, Vinci F, Albertini R, and Larizza D
- Subjects
- Adolescent, Biomarkers analysis, Child, Female, Follow-Up Studies, Humans, Italy epidemiology, Male, Prognosis, Retrospective Studies, Sex Factors, Autoimmune Diseases epidemiology, Graves Disease epidemiology, Hashimoto Disease epidemiology
- Abstract
Background: The incidence of autoimmune thyroid diseases (ATD) may vary with the beginning of reproductive function, although few reports differentiate the incidence before and during the onset of puberty, examining gender bias. We analyzed onset of ATD in a pediatric population to assess gender differences in onset age, disease subtype, pubertal status, autoimmune co-morbidity, family history and treatment, focusing on the interaction between gender and pubertal stage. Patients and methods: We retrospectively recorded 382 children and adolescents with ATD. In each patient physical examination was considered. The presence of other associated autoimmune diseases (AAD) and familial predisposition was also recorded. Results: Predominant prevalence was noted in females compared to males ( p < 0.001), both in Hashimoto's diseases (HD or HT) and Graves' disease (GD) ( p < 0.001). Mean age at diagnosis showed no significant difference between sexes ( p > 0.05). A higher prevalence in pubertal subjects was noted compared to prepubertal ( p < 0.001, particularly HT in early and GD in late pubertal stage), without sexes difference intra-(prepubertal vs. pubertal) and inter-puberty groups (prepubertal vs. early pubertal vs. late pubertal). Both in HT and in GD, the prevalence of autoimmune associated diseases (AAD) was higher in males compared to females ( p = 0.04), with similar distribution according to the pubertal maturation. The familial predisposition was similarly distributed in both genders ( p > 0.05) and into pubertal stages ( p > 0.05). Conclusions: Females are more prone to develop ATD during puberty, earlier in HT than in GD. The effect of puberty is not different between genders, suggesting the role of additional factors other than hormones. The screening for detection of ATD is recommended in all patients with positive family history and other autoimmune diseases, mostly in males. Considerations of gender in pediatrics could be important to define pathogenic mechanisms of ATD and to help in early diagnosis and clinical management., (Copyright © 2020 Calcaterra, Nappi, Regalbuto, De Silvestri, Incardona, Amariti, Bassanese, Clemente, Vinci, Albertini and Larizza.)
- Published
- 2020
- Full Text
- View/download PDF
28. Evaluation of Allostatic Load as a Marker of Chronic Stress in Children and the Importance of Excess Weight.
- Author
-
Calcaterra V, Vinci F, Casari G, Pelizzo G, de Silvestri A, De Amici M, Albertini R, Regalbuto C, Montalbano C, Larizza D, and Cena H
- Abstract
Introduction: Allostatic load (AL) refers to the physiological response associated with the burden of chronic stress. Excessive weight is an important source of physiological stress that promotes a detrimental chronic low-inflammation state. In order to define a correlation between cumulative biological dysregulation and excess weight, we measured AL scores in a pediatric population. Patients and Methods: We enrolled 164 children and adolescents (11.89 ± 3.89). According to their body mass index (BMI) threshold, subjects were classified as normal in the BMI < 75th percentile, overweight in the BMI 75-95th percentile or obese in the BMI >95th percentile. Data based on 16 biomarkers were used to create the AL score. A dichotomous outcome for high AL was defined in those who had more than four dysregulated components. Results: High AL was noted in 88/164 subjects (53.65%), without significant differences between genders ( p = 0.07) or pubertal status ( p = 0.10). Subjects with a high AL, in addition to a higher BMI ( p < 0.001), showed higher WC and WC/HtR ( p < 0.001), triglycerides ( p = 0.002), fasting blood glucose ( p = 0.03), insulin resistance ( p < 0.001), systolic ( p < 0.001) and diastolic blood pressure ( p = 0.001), GGT ( p = 0.01), PCR ( p = 0.01), and calprotectin ( p < 0.01) as well as lower HDL cholesterol ( p = 0.002) than subjects with a low AL. The rate of the cumulative biological dysregulation increased progressively with increases in BMI ( p < 0.001). Conclusions: A high AL was associated with excess weight. AL may be considered a significant factor correlated with increased morbidity in children who are overweight/obese.
- Published
- 2019
- Full Text
- View/download PDF
29. WITHDRAWN: Triglyceride Glucose Index as a Surrogate Measure of Insulin Sensitivity in a Caucasian Pediatric Population
- Author
-
Calcaterra V, Montalbano C, de Silvestri A, Pelizzo G, Regalbuto C, Paganelli V, Albertini R, Cave FD, Larizza D, and Cena H
- Published
- 2019
- Full Text
- View/download PDF
30. Diet and Lifestyle Role in Homocysteine Metabolism in Turner Syndrome.
- Author
-
Calcaterra V, Larizza D, De Giuseppe R, De Liso F, Klersy C, Albertini R, Pozzebon I, Princis MP, Montalbano C, Madè A, and Cena H
- Subjects
- Adolescent, Adult, Diet, Dietary Supplements, Female, Humans, Italy, Life Style, Methylenetetrahydrofolate Reductase (NADPH2) genetics, Middle Aged, Regression Analysis, Retrospective Studies, Turner Syndrome complications, Turner Syndrome diet therapy, Vitamin B 12 Deficiency complications, Vitamins therapeutic use, Young Adult, Homocysteine blood, Turner Syndrome blood, Vitamin B 12 Deficiency blood
- Abstract
Objective: Patients with Turner syndrome (TS) have an unfavorable cardiometabolic profile. Hyperhomocysteinemia is a potential cardiovascular risk factor influenced by genetic and environmental factors, therapies, unbalanced diets and other lifestyle factors. We retrospectively studied the relationship between total plasma homocysteine (Hcy), serum vitamin B12 (B12) and folate concentration in TS patients, taking into account the genetic profile, diet, smoking habits, hormonal therapies and dietary supplements of the subjects., Patients and Methods: We evaluated 50 TS patients (31.5 ± 12.5 years). Medication, including vitamin supplementation, was obtained. Eating habits, cigarette smoking, alcohol and coffee consumption were investigated using phone interviews. Levels of Hcy metabolism parameters were classified by using the relevant cutoff value for an adult population and compared with a reference sample drawn from the general population., Results: Inadequate Hcy and B12 levels were noted, despite vitamin supplementation. Holotranscobalamin (HoloTC) was above the relevant cutoff in the population, and supplemented subjects showed mean levels lower than nonsupplemented subjects (p = 0.005). Dietary supplementation (p = 0.038), lifestyle (coffee consumption, p = 0.01) and hormonal replacement therapy (p = 0.02) are important factors for Hcy metabolism. No genetic influence on Hcy levels was noted. Multivariable regression analysis identified vitamin supplementation (p = 0.045) as the only independent predictor of increased Hcy levels., Conclusion: Cardiovascular risk in TS can be reduced using educational approaches to a healthy lifestyle with dietary guidelines. Besides this, we also recommend measuring HoloTC for the prompt detection of B12 deficiency and to consider hormone replacement therapy in the biochemical assessment of homocysteine in TS., (© 2018 The Author(s) Published by S. Karger AG, Basel.)
- Published
- 2019
- Full Text
- View/download PDF
31. Smoke exposure and cardio-metabolic profile in youth with type 1 diabetes.
- Author
-
Calcaterra V, Winickoff JP, Klersy C, Schiano LM, Bazzano R, Montalbano C, Musella V, Regalbuto C, Larizza D, and Cena H
- Abstract
Background: To evaluate the relationship between smoking and metabolic parameters in patients affected by type 1 diabetes (T1D)., Patients and Methods: We enrolled 104 children and young adults (50 females and 54 males) with T1D (aged 16.4 ± 8.6 years). The subjects were divided into three groups according to their smoking habits: no smoking (NS), passive smoking (PS), active smoking (AS). The physical examination of the participants included nutritional status assessment by anthropometry and pubertal stage according to Marshall and Tanner as well as blood pressure measurement. In all patients, metabolic blood assays including fasting blood glucose, insulin, total cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured. Insulin resistance was determined by glucose disposal rate (eGDR). Physical activity was also recorded., Results: Significant differences in biochemical and functional parameters among the three groups were demonstrated, in particular for systolic (p = 0.002) and diastolic pressure (p = 0.02) and eGDR (p = 0.039). No differences in daily insulin dose (p = 0.75) and glycated hemoglobin (p = 0.39) were observed. AS group had significantly higher blood pressure (p < 0.05) and lower eGDR (p ≤ 0.001) compared to NS and PS. Significant difference was also detected between PS and NS in systolic and diastolic (p = 0.02) pressure and eGDR (p = 0.01). In a multivariable model adjusted for age, gender, BMI and physical activity, smoking habits did not maintain any independent association with metabolic parameters., Conclusion: This is the first study in a Mediterranean population, looking at tobacco smoke and cardio-metabolic factors in youth with T1D. The relationship between smoking and unfavorable metabolic profile was demonstrated. On the basis of these findings, smoking tobacco should be considered an important modifiable risk factor for young patients with diabetes mellitus, highlighting the need for intensified smoking prevention and cessation programs.
- Published
- 2018
- Full Text
- View/download PDF
32. Gynecomastia after euthyroidism restoration in a patient with type 1 diabetes and Graves' disease.
- Author
-
Calcaterra V, Clerici E, Ceolin V, Regalbuto C, and Larizza D
- Abstract
In patients with autoimmune disease, gynecomastia should not be considered as 1 of the first signs of hyperthyroidism, rather it is a breast pathology that can be present even when euthyroidism restoration is achieved. It is unknown whether the autoimmune nature of thyroid disorders or simply the hyperthyroidism effects breast changes.
- Published
- 2018
- Full Text
- View/download PDF
33. Omitting duodenal biopsy in children with suspected celiac disease and extra-intestinal symptoms.
- Author
-
Bozzola M, Meazza C, Gertosio C, Pagani S, Larizza D, Calcaterra V, Luinetti O, Farello G, Tinelli C, and Iughetti L
- Subjects
- Adolescent, Biopsy, Child, Enzyme-Linked Immunosorbent Assay, Female, Genotype, Humans, Italy epidemiology, Male, Polymerase Chain Reaction, Retrospective Studies, Celiac Disease complications, Celiac Disease pathology, Duodenal Diseases complications, Duodenal Diseases pathology
- Abstract
Background: The aim of our study is to evaluate if in children with highly positive serology and HLA-DQ2/DQ8 (triple test, TT) and only extra-intestinal symptoms, it is possible to omit performing an intestinal biopsy for celiac disease (CD) diagnosis, as suggested by the new European Society for Pediatric Gastroenterology, Hepatology and Nutrition ESPGHAN guidelines., Methods: In this retrospective study a total of 105 patients, suspected of having CD because of extra-intestinal symptoms and showing serum tissue transglutaminase antibody (anti-tTG) and anti-endomysial antibody (EMA) measurements and HLA genotyping, were considered for the final analysis (33 boys and 72 girls; age range 1.5-17.6 years)., Results: Histological findings confirmed diagnosis of CD in 97 (92.4%) patients. Forty-one patients (39%) showed anti-tTG >10 times normal values, positive EMA and positive HLA-DQ2/DQ8 (positive TT). All of them had a diagnosis of CD, therefore there were no false positive cases. Sixty-four patients were negative for the TT. In eight cases, CD was ruled out and these were considered true negative cases. In the remaining 56 negative TT patients, intestinal biopsy confirmed CD diagnosis and they were considered false negatives. Based on these results, specificity for the TT was 100% and sensitivity was 42.3%., Conclusions: On the basis of the present study, diagnosis of CD can be reliably performed without a duodenal biopsy in children with only extra-intestinal symptoms.
- Published
- 2017
- Full Text
- View/download PDF
34. A frequent oligogenic involvement in congenital hypothyroidism.
- Author
-
de Filippis T, Gelmini G, Paraboschi E, Vigone MC, Di Frenna M, Marelli F, Bonomi M, Cassio A, Larizza D, Moro M, Radetti G, Salerno M, Ardissino D, Weber G, Gentilini D, Guizzardi F, Duga S, and Persani L
- Subjects
- Cohort Studies, Computational Biology methods, Congenital Hypothyroidism metabolism, Female, High-Throughput Nucleotide Sequencing methods, Humans, Italy, Male, Multifactorial Inheritance genetics, Mutation, Pedigree, Phenotype, Congenital Hypothyroidism genetics
- Abstract
Congenital hypothyroidism (CH), the most frequent form of preventable mental retardation, is predicted to have a relevant genetic origin. However, CH is frequently reported to be sporadic and candidate gene variations were found in <10% of the investigated patients. Here, we characterize the involvement of 11 candidate genes through a systematic Next Generation Sequencing (NGS) analysis. The NGS was performed in 177 unrelated CH patients (94 gland-in-situ; 83 dysgenesis) and in 3,538 control subjects. Non-synonymous or splicing rare variants (MAF < 0.01) were accepted, and their functional impact was predicted by a comprehensive bioinformatic approach and co-segregation studies. The frequency of variations in cases and controls was extended to 18 CH-unrelated genes. At least one rare variant was accepted in 103/177 patients. Monogenic recessive forms of the disease were found in five cases, but oligogenic involvement was detected in 39 patients. The 167 variations were found to affect all genes independently of the CH phenotype. These findings were replicated in an independent cohort of additional 145 CH cases. When compared to 3,538 controls, the CH population was significantly enriched with disrupting variants in the candidate genes (P = 5.5 × 10-7), but not with rare variations in CH-unrelated genes. Co-segregation studies of the hypothyroid phenotype with multiple gene variants in several pedigrees confirmed the potential oligogenic origin of CH. The systematic NGS approach reveals the frequent combination of rare variations in morphogenetic or functional candidate genes in CH patients independently of phenotype. The oligogenic origin represents a suitable explanation for the frequent sporadic CH occurrence., (© The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.)
- Published
- 2017
- Full Text
- View/download PDF
35. Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter.
- Author
-
Ferraioli G, Calcaterra V, Lissandrin R, Guazzotti M, Maiocchi L, Tinelli C, De Silvestri A, Regalbuto C, Pelizzo G, Larizza D, and Filice C
- Subjects
- Adolescent, Bayes Theorem, Child, Child, Preschool, Cross-Sectional Studies, Fatty Liver blood, Female, Humans, Liver diagnostic imaging, Male, Prospective Studies, Reference Values, Ultrasonography, Elasticity Imaging Techniques, Fatty Liver complications, Fatty Liver diagnostic imaging, Overweight complications, Pediatric Obesity complications
- Abstract
Background: To assess the clinical validity of controlled attenuation parameter (CAP) in the diagnosis of hepatic steatosis in a series of overweight or obese children by using the imperfect gold standard methodology., Methods: Consecutive children referred to our institution for auxological evaluation or obesity or minor elective surgery were prospectively enrolled. Anthropometric and biochemical parameters were recorded. Ultrasound (US) assessment of steatosis was carried out using ultrasound systems. CAP was obtained with the FibroScan 502 Touch device (Echosens, Paris, France). Pearson's or Spearman's rank correlation coefficient were used to test the association between two study variables. Optimal cutoff of CAP for detecting steatosis was 249 dB/m. The diagnostic performance of dichotomized CAP, US, body mass indexes (BMI), fatty liver index (FLI) and hepatic steatosis index (HSI) was analyzed using the imperfect gold standard methodology., Results: Three hundred five pediatric patients were enrolled. The data of both US and CAP were available for 289 children. Steatosis was detected in 50/289 (17.3%) children by US and in 77/289 (26.6%) by CAP. A moderate to good correlation was detected between CAP and BMI (r = 0.53), FLI (r = 0.55) and HSI (r = 0.56). In obese children a moderate to good correlation between CAP and insulin levels (r = 0.54) and HOMA-IR (r = 0.54) was also found. Dichotomized CAP showed a performance of 0.70 (sensitivity, 0.72 [0.64-0.79]; specificity, 0.98 [0.97-0.98], which was better than that of US (performance, 0.37; sensitivity, 0.46 [0.42-0.50]; specificity, 0.91 [0.89-0.92]), BMI (performance, 0.22; sensitivity, 0.75 [0.73-0.77]; specificity, 0.57 [0.55-0.60]) and FLI or HSI., Conclusions: For the evaluation of liver steatosis in children CAP performs better than US, which is the most widely used imaging technique for screening patients with a suspicion of liver steatosis. A cutoff value of CAP of 249 dB/m rules in liver steatosis with a very high specificity.
- Published
- 2017
- Full Text
- View/download PDF
36. Neoplasia in Turner syndrome. The importance of clinical and screening practices during follow-up.
- Author
-
Larizza D, Albanesi M, De Silvestri A, Accordino G, Brazzelli V, Maffè GC, and Calcaterra V
- Subjects
- Adenomyoma complications, Adenomyoma drug therapy, Adenomyoma pathology, Adult, Chromosomes, Human, X genetics, Female, Follow-Up Studies, Gallbladder Neoplasms complications, Gallbladder Neoplasms drug therapy, Gallbladder Neoplasms pathology, Genetic Predisposition to Disease, Growth Hormone administration & dosage, Hormone Replacement Therapy, Humans, Karyotype, Karyotyping, Middle Aged, Neoplasms complications, Neoplasms pathology, Turner Syndrome complications, Turner Syndrome drug therapy, Turner Syndrome pathology, Adenomyoma genetics, Gallbladder Neoplasms genetics, Neoplasms genetics, Turner Syndrome genetics
- Abstract
Aim of the Study: Turmer syndrome (TS) patients show increased morbidity due to metabolic, autoimmune and cardiovascular disorders. A risk of neoplasia is also reported. Here, we review the prevalence of neoplasia in a cohort of Turner patients., Methods: We retrospectively evaluated 87 TS women. Follow-up included periodic ultrasound of the neck, abdominal and pelvic organs, dermatologic evaluation and fecal occult blood test. Karyotype was 45,X in 46 patients. During follow-up, 63 girls were treated with growth hormone, 65 with estro-progestin replacement therapy and 20 with L-thyroxine. Autoimmune diseases were present in 29 TS., Results: A total of 17 neoplasms in 14 out of 87 patients were found. Six skin neoplasia, 3 central nervous system tumors, 3 gonadal neoplasia, 2 breast tumors, 1 hepatocarcinoma, 1 carcinoma of the pancreas and 1 follicular thyroid cancer were detected. Age at tumor diagnosis was higher in 45,X pts than in those with other karyotypes (p = 0.003). Adenomioma gallbladdder (AG) was detected in 15.3% of the patients, with a lower age in girls at diagnosis with an associated neoplasia in comparison with TS without tumors (p = 0.017). No correlation between genetic make up, treatment, associated autoimmune diseases and neoplastia was found., Conclusion: In our TS population an increased neoplasia prevalence was reported. A high prevalence of AG was also noted and it might be indicative of a predisposition to neoplasia. Further studies are needed to define the overall risk for neoplasia, and to determine the role of the loss of the X-chromosome and hormonal therapies., (Copyright © 2016 Elsevier Masson SAS. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
37. Music benefits on postoperative distress and pain in pediatric day care surgery.
- Author
-
Calcaterra V, Ostuni S, Bonomelli I, Mencherini S, Brunero M, Zambaiti E, Mannarino S, Larizza D, Albertini R, Tinelli C, and Pelizzo G
- Abstract
Postoperative effect of music listening has not been established in pediatric age. Response on postoperative distress and pain in pediatric day care surgery has been evaluated. Forty-two children were enrolled. Patients were randomly assigned to the music-group (music intervention during awakening period) or the non-music group (standard postoperative care). Slow and fast classical music and pauses were recorded and played via ambient speakers. Heart rate, blood pressure, oxygen saturation, glucose and cortisol levels, faces pain scale and Face, Legs, Activity, Cry, Consolability (FLACC) Pain Scale were considered as indicators of response to stress and pain experience. Music during awakening induced lower increase of systolic and diastolic blood pressure levels. The non-music group showed progressive increasing values of glycemia; in music-group the curve of glycemia presented a plateau pattern (P<0.001). Positive impact on reactions to pain was noted using the FLACC scale. Music improves cardiovascular parameters, stress-induced hyperglycemia. Amelioration on pain perception is more evident in older children. Positive effects seems to be achieved by the alternation of fast, slow rhythms and pauses even in pediatric age.
- Published
- 2014
- Full Text
- View/download PDF
38. Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome.
- Author
-
Castronovo C, Rossetti R, Rusconi D, Recalcati MP, Cacciatore C, Beccaria E, Calcaterra V, Invernizzi P, Larizza D, Finelli P, and Persani L
- Subjects
- Adolescent, Child, Comparative Genomic Hybridization, Female, Fertility, Humans, Karyotyping, Mosaicism, Puberty, Chromosomes, Human, X, Gene Dosage, Menarche genetics, Ovarian Diseases pathology, Ovary physiology, Turner Syndrome genetics
- Abstract
Study Question: What is the burden of X chromosome mosaicism in the occurrence of spontaneous menarche (SM) in Turner syndrome (TS)?, Summary Answer: SM was significantly associated with X chromosome mosaicism in the TS patients; a mosaicism with around 10% euploid cell line may predict spontaneous pubertal development when determined by molecular-cytogenetic techniques on uncultivated tissues., What Is Known Already: Spontaneous puberty can be observed in a minority of patients with TS, more frequently, but not exclusively, in those with a high level of 46,XX/45,X mosaicism at standard karyotype. The genetic mechanisms contributing to ovarian function in TS patients are still not determined. However, submicroscopic X-linked and autosomal copy number variations (CNVs) have recently emerged as an important genetic risk category for premature ovarian insufficiency and may be involved in modulating the TS ovarian phenotype., Study Design, Size, Duration: A group of 40 patients with a diagnosis of TS at conventional karyotyping participated in the study; 6 patients had SM and 34 patients had primary amenorrhoea (PA). All clinical data and the patients' DNA samples were collected over the years at a single paediatric clinic., Participants/materials, Setting, Methods: The patients' samples were used to perform both genetic (Copy Number Assay) and molecular-cytogenetic (array-CGH and iFISH, interphase-FISH) analyses in order to evaluate the X chromosome mosaicism rate and to detect possible rare CNVs of genes with a known or predicted role in female fertility., Main Results and the Role of Chance: All TS patients showed variable percentages of the 46,XX lineage, but these percentages were higher in the SM group (P < 0.01). A mosaicism around 10% for the euploid cell line may predict spontaneous pubertal development when determined by molecular-cytogenetic techniques performed in uncultivated tissues. A few CNVs involving autosomal and X-linked ovary-related loci were identified by array-CGH analysis and confirmed by real-time quantitative PCR, including a BMP15 gene duplication at Xp11.22, a deletion interrupting the PAPPA gene at 9q33.1, and an intragenic duplication involving the PDE8A gene at 15q25.3., Limitations, Reasons for Caution: This is a pilot study on a relatively small sample size and confirmation in larger TS cohorts may be required. The ovarian tissue could not be studied in any patients and in a subgroup of patients, the mosaicism was estimated in tissues of different embryonic origin., Wider Implications of the Findings: The combined determination of X chromosome mosaicism by molecular and molecular-cytogenetic techniques may become useful for the prediction of SM in TS. The detection of CNVs in both X-linked and autosomal ovary-related genes further suggests gene dosage as a relevant mechanism contributing to the ovarian phenotype of TS patients. These CNVs may pinpoint novel candidates relevant to female fertility and generate further insights into the mechanisms contributing to ovarian function., Study Funding/competing Interest(s): This study was funded by Telethon Foundation (grant no: GGP09126 to L.P.), the Italian Ministry of the University and Research (grant number: 2006065999 to P.F.) and a Ministry of Health grant 'Ricerca Corrente' to IRCCS Istituto Auxologico Italiano (grant number: 08C704-2006). The authors have no conflict of interest to declare.
- Published
- 2014
- Full Text
- View/download PDF
39. Paediatric tubercular spinal abscess involving the dorsal, lumbar and sacral regions and causing spinal cord compression.
- Author
-
Bozzola E, Bozzola M, Magistrelli A, Calcaterra V, Larizza D, Lancella L, and Villani A
- Subjects
- Adolescent, Antitubercular Agents therapeutic use, Drug Therapy, Combination, Epidural Abscess drug therapy, Epidural Abscess microbiology, Epidural Abscess surgery, Humans, Isoniazid therapeutic use, Lumbosacral Region pathology, Lumbosacral Region surgery, Male, Mycobacterium tuberculosis isolation & purification, Pyrazinamide therapeutic use, Rare Diseases, Rifampin therapeutic use, Spinal Cord Compression diagnosis, Treatment Outcome, Tuberculin Test, Epidural Abscess complications, Epidural Abscess diagnosis, Laminectomy, Spinal Cord Compression etiology, Spinal Cord Compression surgery, Thoracic Vertebrae pathology, Thoracic Vertebrae surgery, Tuberculosis, Spinal complications
- Abstract
Tubercular spinal localization is very rare (5%) in paediatric age. We report the unusual case of a child with a history of bacillus Calmette-Guerin vaccination who presented with lymphadenitis in the absence of pulmonary involvement. Despite appropriate anti-tubercular therapy, the patient developed spinal tuberculosis with cord compression. Urgent surgical decompression was performed: laminectomy was done at D3-D5 levels and the higher abscess was then flushed using a catheter, decompressing the cauda equina. Our findings suggest that diagnosis of tuberculosis should be considered even in light of anamnestic vaccination at birth, and that surgical treatment should be rapidly provided in the event of spinal cord compression to avoid devastating sequelae.
- Published
- 2013
40. Central precocious puberty and granulosa cell ovarian tumor in an 8-year old female.
- Author
-
Calcaterra V, Nakib G, Pelizzo G, Rundo B, Anna Rispoli G, Boghen S, Bonetti F, Del Monte B, Gertosio C, and Larizza D
- Abstract
Ovarian tumors associated with hormonal changes of the peripheral iso-sexual precocious puberty are of common presentation. We describe here a rare case of juvenile granulosa cell tumor in a female with central precocious puberty (CPP). An 8-year old girl with CPP presented with vaginal bleeding four months after the diagnosis and before starting treatment with gonadotropin-releasing hormone (GnRH)-analogs. Suppression of basal follicle-stimulating hormone (FSH) level, elevation of serum estradiol, progesterone and Cancer Antigen-125 were documented. Abdominal ultrasound examination (US) and magnetic resonance imaging showed a pelvic mass affecting the left ovary. A left salpingo-oophorectomy was performed and the mass was totally resected. Juvenile granulosa cell ovarian tumor was diagnosed. One month post surgery, estradiol and progesterone decreased to values of the first evaluation and FSH increased; Cancer Antigen-125 resulted normal while ultrasound pelvic examination showed absence of pelvic masses. In our patient, the tumor had grown very quickly since hormonal data demonstrated a CPP without any evidence of ovarian mass on US only four months before diagnosis. The overstimulation of the FSH or aberrant activation of FSH receptors may have contributed to the development of the mass.
- Published
- 2013
- Full Text
- View/download PDF
41. Growth hormone deficiency in a patient with becker muscular dystrophy: a pediatric case report.
- Author
-
Calcaterra V, Malvezzi A, Toglia R, Berardinelli A, Bozzola E, Bozzola M, and Larizza D
- Abstract
Objective. To describe a biochemical growth hormone (GH) deficiency and to evaluate therapeutic result in a six-year-old male with Becker muscular dystrophy (BMD). Methods. GH peak was evaluated after response to arginine and insulin. Bone age was evaluated according to Greulich and Pyle method. Results. The GH-supplementary therapy was very effective in terms of growth gain. Conclusion. The possibility of a growth hormone deficiency and treatment with GH in patients with BMD cannot be excluded, especially considering the good therapeutic response.
- Published
- 2013
- Full Text
- View/download PDF
42. Adiponectin, IL-10 and metabolic syndrome in obese children and adolescents.
- Author
-
Calcaterra V, De Amici M, Klersy C, Torre C, Brizzi V, Scaglia F, Albanesi M, Albertini R, Allais B, and Larizza D
- Subjects
- Adolescent, Body Mass Index, Child, Female, Humans, Immunoenzyme Techniques, Incidence, Italy epidemiology, Male, Metabolic Syndrome epidemiology, Metabolic Syndrome etiology, Obesity complications, Obesity epidemiology, Adiponectin blood, Interleukin-10 blood, Metabolic Syndrome blood, Obesity blood
- Abstract
The metabolic syndrome (MetS) is a common basis for the development of atherogenic cardiovascular disease. Adiponectin has been demonstrated to be insulin-sensitizing and an anti-atherogenic factor and is considered a key ofMetS. It was suggested that IL-10 may be involved in the inflammatory network of MetS in relation to adiponectin. We examined the relationship between adiponectin, IL-10 and MetS in pediatric obese patients. MetS components were assessed in 70 severely obese and 30 non-obese children and adolescents. Serum levels of adiponectin and IL-10 were measured in these subjects. Serum adiponectin levels were significantly lower (p < 0.001) and levels of IL-10 were significantly higher (p = 0.012) in obese subjects. MetS was present in 35.71% of obese patients. Patients with MetS showed a borderline significant decrease in serum adiponectin levels and significantly increased IL-10 levels when compared to those without MetS (p = 0.051 and p = 0.031, respectively); the differences in adiponectin and IL-10 values were controlled to the effect of BMI. No correlation between adiponectin and IL-10 levels was found. Our obese children showed hypoadiponectin and hyper-IL10 values. MetS was not associated with low IL-10. We probably observe a first phase of the complex mechanism implicated in the development of the MetS in children.
- Published
- 2009
43. Variations of the perforin gene in patients with type 1 diabetes.
- Author
-
Orilieri E, Cappellano G, Clementi R, Cometa A, Ferretti M, Cerutti E, Cadario F, Martinetti M, Larizza D, Calcaterra V, D'Annunzio G, Lorini R, Cerutti F, Bruno G, Chiocchetti A, and Dianzani U
- Subjects
- Adolescent, Adult, Amino Acid Substitution, Cohort Studies, DNA Primers, Diabetes Mellitus, Type 1 immunology, Female, Gene Frequency, Genetic Predisposition to Disease, HLA-DQ Antigens genetics, HLA-DQ alpha-Chains, HLA-DQ beta-Chains, Humans, Italy, Male, Perforin, Polymorphism, Single Nucleotide, Reference Values, Diabetes Mellitus, Type 1 genetics, Genetic Variation, Pore Forming Cytotoxic Proteins genetics
- Abstract
Objective: Perforin plays a key role in cell-mediated cytotoxicity. Mutations of its gene, PRF1, cause familial hemophagocytic lymphohistiocytosis but have also been associated with lymphomas and the autoimmune/lymphoproliferative syndrome. The aim of this work was to investigate the role of PRF1 variations in type 1 diabetes., Research Design and Methods: We typed for the N252S and A91V variations in an initial population of 352 type 1 diabetic patients and 816 control subjects and a second population of 365 patients and 964 control subjects. Moreover, we sequenced the coding sequence and intron-exons boundaries in 200 patients and 300 control subjects., Results: In both cohorts, allelic frequency of N252S was significantly higher in patients than in control subjects (combined cohorts: 1.5 vs. 0.4%; odds ratio 6.68 [95% CI 1.83-7.48]). Sequencing of the entire coding region detected one novel mutation in one patient, causing a P477A amino acid change not detected in 199 patients and 300 control subjects. Typing for HLA-DQA1 and DQB1 alleles showed that type 1 diabetes-predisposing DQ alpha/DQ beta heterodimers were less frequent in patients carrying N252S or P477A than in those carrying wild-type PRF1. We previously found that natural killer (NK) activity is not decreased in most N252S heterozygotes, but we detected one whose NK activity was normal at the age of 12 but strikingly low in early childhood. Here, we discovered that NK function was low in three heterozygotes in early childhood, one homozygous adult, and in the subject carrying P477A., Conclusions: These data suggest that N252S and possibly other PRF1 variations are susceptibility factors for type 1 diabetes development.
- Published
- 2008
- Full Text
- View/download PDF
44. Delineation of the ADULT syndrome phenotype due to arginine 298 mutations of the p63 gene.
- Author
-
Rinne T, Spadoni E, Kjaer KW, Danesino C, Larizza D, Kock M, Huoponen K, Savontaus ML, Aaltonen M, Duijf P, Brunner HG, Penttinen M, and van Bokhoven H
- Subjects
- Adult, Child, Female, Humans, Limb Deformities, Congenital genetics, Male, Middle Aged, Mutation, Missense, Phenotype, Syndrome, Tooth Abnormalities genetics, Abnormalities, Multiple genetics, Arginine, Ectodermal Dysplasia genetics, Genes, Tumor Suppressor, Transcriptional Activation
- Abstract
The ADULT syndrome (Acro-Dermato-Ungual-Lacrimal-Tooth, OMIM 103285) is a rare ectodermal dysplasia associated with limb malformations and caused by heterozygous mutations in p63. ADULT syndrome has clinical overlap with other p63 mutation syndromes, such as EEC (OMIM 604292), LMS (OMIM 603543), AEC (106260), RHS (129400) and SHFM4 (605289). ADULT syndrome characteristics are ectrodactyly, ectodermal dysplasia, mammary gland hypoplasia and normal lip and palate. The latter findings allow differentiation from EEC syndrome. LMS differs by milder ectodermal involvement. Here, we report three new unrelated ADULT syndrome families, all with mutations of arginine 298. On basis of 16 patients in five families with R298 mutation, we delineate the ADULT syndrome phenotype. In addition, we have documented a gain-of-function effect on the dNp63gamma isoform caused by this mutation. We discuss the possible relevance of oral squamous cell carcinoma in one patient, who carries this p63 germline mutation.
- Published
- 2006
- Full Text
- View/download PDF
45. Do reduced levels of steroid 21-hydroxylase confer a survival advantage in fetuses affected by sex chromosome aberrations?
- Author
-
Mantovani V, Dondi E, Larizza D, Cisternino M, Bragliani M, Viggiani M, Martinetti M, and Cuccia M
- Subjects
- 17-alpha-Hydroxyprogesterone metabolism, Adrenocorticotropic Hormone metabolism, Female, Fetal Viability physiology, Humans, Klinefelter Syndrome genetics, Male, Mutation, Steroid 21-Hydroxylase genetics, Turner Syndrome genetics, Fetal Viability genetics, Fetus physiology, Sex Chromosome Aberrations, Steroid 21-Hydroxylase metabolism
- Abstract
We investigated whether molecular defects in the CYP21 gene were detectable in two common sex chromosome aberrations, the Turner and the Klinefelter syndromes. We found abnormal 17-hydroxyprogesterone levels after adrenal stimulation in 26/60 (43.3%) patients affected by these chromosome aberrations, as compared with only 11/68 (16.2%) normal controls (P=0.0014, odds ratio 4.0). Screening of the CYP21 gene identified a single Val281Leu missense mutation in exon 7 in 9/63 (14.3%) of the patients, all nine of whom were heterozygote carriers; the mutation frequency was significantly higher than in the general population (P=0.007, odds ratio=3.5). The hormonal and molecular data indicate that these common sex chromosome aberrations are associated with a remarkably high frequency of steroidogenic defects. It may be hypothesised that reduced levels of steroid 21-hydroxylase could confer a survival advantage, leading to a successful pregnancy.
- Published
- 2002
- Full Text
- View/download PDF
46. Olfactory receptor-gene clusters, genomic-inversion polymorphisms, and common chromosome rearrangements.
- Author
-
Giglio S, Broman KW, Matsumoto N, Calvari V, Gimelli G, Neumann T, Ohashi H, Voullaire L, Larizza D, Giorda R, Weber JL, Ledbetter DH, and Zuffardi O
- Subjects
- Chromosome Deletion, Chromosomes, Artificial, Bacterial genetics, Chromosomes, Human, Pair 8 genetics, Cloning, Molecular, Contig Mapping, Crossing Over, Genetic genetics, DNA Probes genetics, Electrophoresis, Gel, Pulsed-Field, Female, Genes, Duplicate genetics, Heterozygote, Humans, In Situ Hybridization, Fluorescence, Male, Microsatellite Repeats genetics, Chromosome Breakage genetics, Chromosome Inversion, Multigene Family genetics, Polymorphism, Genetic genetics, Receptors, Odorant genetics
- Abstract
The olfactory receptor (OR)-gene superfamily is the largest in the mammalian genome. Several of the human OR genes appear in clusters with > or = 10 members located on almost all human chromosomes, and some chromosomes contain more than one cluster. We demonstrate, by experimental and in silico data, that unequal crossovers between two OR gene clusters in 8p are responsible for the formation of three recurrent chromosome macrorearrangements and a submicroscopic inversion polymorphism. The first two macrorearrangements are the inverted duplication of 8p, inv dup(8p), which is associated with a distinct phenotype, and a supernumerary marker chromosome, +der(8)(8p23.1pter), which is also a recurrent rearrangement and is associated with minor anomalies. We demonstrate that it is the reciprocal of the inv dup(8p). The third macrorearrangment is a recurrent 8p23 interstitial deletion associated with heart defect. Since inv dup(8p)s originate consistently in maternal meiosis, we investigated the maternal chromosomes 8 in eight mothers of subjects with inv dup(8p) and in the mother of one subject with +der(8), by means of probes included between the two 8p-OR gene clusters. All the mothers were heterozygous for an 8p submicroscopic inversion that was delimited by the 8p-OR gene clusters and was present, in heterozygous state, in 26% of a population of European descent. Thus, inversion heterozygosity may cause susceptibility to unequal recombination, leading to the formation of the inv dup(8p) or to its reciprocal product, the +der(8p). After the Yp inversion polymorphism, which is the preferential background for the PRKX/PRKY translocation in XX males and XY females, the OR-8p inversion is the second genomic polymorphism that confers susceptibility to the formation of common chromosome rearrangements. Accordingly, it may be possible to develop a profile of the individual risk of having progeny with chromosome rearrangements.
- Published
- 2001
- Full Text
- View/download PDF
47. Thyroid volume is progressively reduced as a sequela of neck irradiation for childhood Hodgkin's disease.
- Author
-
Bossi G, Larizza D, Sommaruga G, Corbella F, Klersy C, and Aricò M
- Subjects
- Adolescent, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Atrophy, Child, Child, Preschool, Combined Modality Therapy, Female, Hodgkin Disease drug therapy, Humans, Hypothyroidism etiology, Infant, Male, Neck radiation effects, Thyroid Function Tests, Thyroid Gland radiation effects, Hodgkin Disease radiotherapy, Radiation Injuries pathology, Radiotherapy adverse effects, Thyroid Gland pathology
- Abstract
Thyroid volume reduction was observed, among 25 subjects off-therapy after Hodgkin's disease. The volume reduction was related to dose (p = 0.014) and time from radiotherapy (p = 0.01). The correlation was very specific since all patients with reduced volume had hypothyroidism, but not very sensitive since 25% of subjects with thyroid dysfunction had normal gland volume.
- Published
- 1998
48. Thyroid function is not affected by second exposure to erwinia asparaginase for childhood acute lymphoblastic leukemia.
- Author
-
Bossi G, Larizza D, and Conter V
- Subjects
- Adolescent, Antineoplastic Agents adverse effects, Asparaginase adverse effects, Child, Child, Preschool, Female, Humans, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma physiopathology, Thyroid Gland drug effects, Antineoplastic Agents administration & dosage, Asparaginase administration & dosage, Precursor Cell Lymphoblastic Leukemia-Lymphoma drug therapy, Thyroid Gland physiopathology
- Published
- 1997
49. An analysis of Xq deletions.
- Author
-
Maraschio P, Tupler R, Barbierato L, Dainotti E, Larizza D, Bernardi F, Hoeller H, Garau A, and Tiepolo L
- Subjects
- Adolescent, Adult, Blotting, Southern, Chromosome Mapping, Female, Humans, In Situ Hybridization, Fluorescence, Karyotyping, Middle Aged, Gene Deletion, X Chromosome
- Abstract
We characterized by fluorescence in situ hybridization and Southern blotting 14 partial Xq monosomies, 11 due to terminal deletions and 3 secondary to X/autosome translocations. Three cases were mosaics with a XO cell line. In view of the possible role played by telomeres in chromosome segregation, we hypothesize a relationship between the loss of telomeric sequences in terminal deletions and the presence of 45,X cells. A correlation between phenotype and extent of deletion reveal that there is no correspondence between the size of the deletion and impairment of gonadal function. Turner stigmata are absent in patients without an XO cell line, when the breakpoint is distal to Xq24. A low birthweight is present whenever the breakpoint is at q22 or more proximal.
- Published
- 1996
- Full Text
- View/download PDF
50. Balanced autosomal translocations and ovarian dysgenesis.
- Author
-
Tupler R, Barbierato L, Larizza D, Sampaolo P, Piovella F, and Maraschio P
- Subjects
- Adolescent, Female, Humans, In Situ Hybridization, Fluorescence, Karyotyping, Polymorphism, Genetic, Gonadal Dysgenesis genetics, Ovary abnormalities, Translocation, Genetic genetics
- Abstract
We report two unrelated women with gonadal dysgenesis, and a (6;15)(p21.3;q15) and a (8;9)(p11.2;q12) balanced translocation, respectively. The patients were of normal stature and showed no phenotypic abnormality or malformation other than ovarian failure. We are not aware of other reports of balanced autosomal translocations associated with gonadal dysgenesis in women. The occurrence of chromosome anomaly and sterility in the two females may be coincidental. However, studies on mouse gametic progression indicate that balanced autosomal translocations can cause oocyte degeneration and reduction of reproductive lifespan. On the basis of these observations, we cannot exclude that the ovarian failure in our patients is the result of oocyte degeneration because of as yet unidentified consequences of the balanced translocations.
- Published
- 1994
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.